Schedule 13D ownership disclosure
COGENT BIOSCIENCES INC
Common Stock, $0.001 par value · CUSIP: 19240Q201
Event date: 2026-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Fairmount Funds Management LLCReported CIK 0001802528
Shares: 15,356,918.00 · Class: 8.6%
- Fairmount Healthcare Fund II GP LLCReported CIK 0001830382
Shares: 15,356,918.00 · Class: 8.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-038056
- Form type
- SCHEDULE 13D/A
- Filer
- Cogent Biosciences, Inc.
- CIK
- CIK 1622229
- Filed
- Mar 31, 2026
- Reporting period
- Mar 31, 2026
- Description
- Schedule 13D beneficial ownership